4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-23-056801
Chief Executive Officer acquired 180,108 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2023-11-26 | Grant or award | +180,108 | 416,999 | D |
Loading xslF345X05/doc4.xml…